http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101590150-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101590150-B1 |
| titleOfInvention | Pharmaceutical composition for enhancing transplantation rate of stem cells and preparation method thereof |
| abstract | The present invention relates to a composition for enhancing the viability of a stem cell comprising a physiologically active peptide and a chimeric peptide composed of a peptide having an ability to adhere to a fibrin gel, and a method for preparing the same, and more particularly, to a method for producing a biologically active peptide, The inventors of the present invention synthesized chimeric peptides linked with peptides and confirmed that the loss of physiologically active peptides in vivo was reduced as a result of mixing of stem cells and fibrin gels. As a result, it was confirmed that peptides having physiologically active peptides and fibrin gel- The chimeric peptide can be useful as a composition for enhancing stem cell viability and a method for producing the same. |
| priorityDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 181.